PRESS RELEASE published on 08/09/2023 at 07:45, 2 years 10 months ago Marinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories Co. Ltd.
PRESS RELEASE published on 07/27/2023 at 07:45, 2 years 10 months ago Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico
PRESS RELEASE published on 07/13/2023 at 07:45, 2 years 11 months ago Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan
PRESS RELEASE published on 06/21/2023 at 17:00, 3 years ago Marinomed Biotech AG: Annual General Meeting elects Dr. Eva Hofstädter-Thalmann as a new member of the Supervisory Board
PRESS RELEASE published on 06/15/2023 at 07:45, 3 years ago Marinomed Biotech AG prepares launch of Carragelose eye drops in 2024
PRESS RELEASE published on 05/23/2023 at 07:45, 3 years 1 month ago Marinomed Biotech AG reports best first quarter in company history
PRESS RELEASE published on 04/19/2023 at 07:45, 3 years 2 months ago Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023
PRESS RELEASE published on 04/12/2023 at 07:45, 3 years 2 months ago Marinomed Biotech AG publishes clinical data on the effectiveness of its Carragelose nasal spray in the treatment of hay fever
PRESS RELEASE published on 03/14/2023 at 07:45, 3 years 3 months ago Marinomed Biotech AG reports positive clinical data for the Carragelose decongestant nasal spray
PRESS RELEASE published on 02/16/2023 at 07:45, 3 years 4 months ago Marinomed Biotech AG announces preliminary revenue for 2022 with double-digit growth for Carragelose
Published on 06/27/2026 at 01:40, 2 hours 56 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 4 hours 36 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 5 hours 36 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 5 hours 46 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 6 hours 21 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 4 hours 30 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 4 hours 31 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 5 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 5 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 5 hours 8 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 07:00, 21 hours 36 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 07:30, 1 day 21 hours ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
